We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+2.2%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$43.6B
AUM Growth
+$2.01B
(+4.8%)
Cap. Flow
+$1.75B
Cap. Flow
% of AUM
4%
Top 10 Holdings %
Top 10 Hldgs %
18.28%
Holding
1,493
New
278
Increased
387
Reduced
400
Closed
399
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$674M |
| 2 |
IBM
IBM
|
+$408M |
| 3 |
Toronto Dominion Bank
TD
|
+$392M |
| 4 |
Biogen
BIIB
|
+$340M |
| 5 |
Boeing
BA
|
+$319M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$366M |
| 2 |
CVS Health
CVS
|
+$350M |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
+$333M |
| 4 |
TSMC
TSM
|
+$323M |
| 5 |
Merck
MRK
|
+$283M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.47% |
| 2 | Healthcare | 17.17% |
| 3 | Financials | 16.49% |
| 4 | Consumer Discretionary | 12.16% |
| 5 | Industrials | 11.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KBAL
926
DELISTED
Kimball International
KBAL
| $662K | ﹤0.01% |
38,852
-205,395
| -84% | -$3.63M |
|
927
American Financial Group
AFG
$11.9B
| $651K | ﹤0.01% |
+5,800
| New | +$649K |
|
928
IQVIA
IQV
$39.8B
| $648K | ﹤0.01% |
6,600
| – | – |
|
929
Donegal Group Class A
DGICA
$699M
| $644K | ﹤0.01% |
40,787
| – | – |
|
|
ORIG
930
DELISTED
Ocean Rig UDW Inc. Class A Common Shares
ORIG
| $644K | ﹤0.01% |
+25,538
| New | +$671K |
|
|
SBR
931
Sabine Royalty Trust
SBR
$1.06B
| $636K | ﹤0.01% |
14,473
+7,300
| +102% | +$327K |
|
932
GE Aerospace
GE
$379B
| $633K | ﹤0.01% |
9,796
-1,373,091
| -99% | -$102M |
|
933
Xencor
XNCR
$1.59B
| $630K | ﹤0.01% |
+21,018
| New | +$550K |
|
|
CRR
934
DELISTED
Carbo Ceramics Inc.
CRR
| $611K | ﹤0.01% |
84,227
-119,033
| -59% | -$1.03M |
|
|
LQ
935
DELISTED
La Quinta Holdings Inc.
LQ
| $601K | ﹤0.01% |
31,800
-440,846
| -93% | -$8.33M |
|
|
GPP
936
DELISTED
Green Plains Partners LP
GPP
| $600K | ﹤0.01% |
34,500
+13,000
| +60% | +$232K |
|
|
CXO
937
DELISTED
CONCHO RESOURCES INC.
CXO
| $586K | ﹤0.01% |
+3,900
| New | +$595K |
|
938
NXP Semiconductors
NXPI
$59.5B
| $585K | ﹤0.01% |
+5,000
| New | +$603K |
|
939
Crown Holdings
CCK
$13B
| $584K | ﹤0.01% |
+11,500
| New | +$614K |
|
940
Stantec
STN
$8.38B
| $584K | ﹤0.01% |
23,700
-94,800
| -80% | -$2.56M |
|
|
TGB
941
Trekor Metals
TGB
$3.18B
| $580K | ﹤0.01% |
+492,200
| New | +$795K |
|
942
Buckle
BKE
$2.4B
| $574K | ﹤0.01% |
+25,910
| New | +$544K |
|
|
TNH
943
DELISTED
Terra Nitrogen
TNH
| $566K | ﹤0.01% |
6,743
-16,041
| -70% | -$1.34M |
|
944
ArcBest
ARCB
$3.07B
| $563K | ﹤0.01% |
+17,560
| New | +$612K |
|
945
PRA Group
PRAA
$718M
| $554K | ﹤0.01% |
+14,575
| New | +$532K |
|
|
ATVI
946
DELISTED
Activision Blizzard
ATVI
| $553K | ﹤0.01% |
8,200
-235,657
| -97% | -$16.6M |
|
|
CWEN.A
947
DELISTED
Clearway Energy Class A
CWEN.A
| $543K | ﹤0.01% |
+33,050
| New | +$571K |
|
|
MNTA
948
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $536K | ﹤0.01% |
+29,506
| New | +$492K |
|
949
APA Corp
APA
$14.3B
| $535K | ﹤0.01% |
13,900
-66,200
| -83% | -$2.66M |
|
950
Matrix Service
MTRX
$329M
| $532K | ﹤0.01% |
38,865
+13,266
| +52% | +$218K |
|
Similar funds
VGA
Arrowstreet Capital's Q1 2018 Portfolio in Review
As of Q1 2018, Arrowstreet Capital held 1,493 positions worth $43.6B, up 4.8% from $41.6B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Arrowstreet Capital deployed $1.75B of net new capital in Q1 2018, opening 278 new positions and adding to 387 existing holdings. Its largest new stake was AB InBev: 2,063,707 shares worth $227M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Philip Morris, an estimated $366M trimmed.
- Arrowstreet Capital's largest Q1 2018 buy was AB InBev: 2,063,707 shares worth $227M.
- Arrowstreet Capital added most to AbbVie in Q1 2018, an estimated $674M increase.
- Arrowstreet Capital's biggest Q1 2018 reduction was Philip Morris, cutting an estimated $366M.
- Arrowstreet Capital fully exited iShares MSCI South Korea ETF in Q1 2018, selling an estimated $271M.
- Arrowstreet Capital's ten largest holdings make up 18% of its $43.6B portfolio in Q1 2018.
- Arrowstreet Capital opened 278 new positions and closed 399 in Q1 2018.
- Arrowstreet Capital's portfolio value rose 4.8% quarter-over-quarter to $43.6B.
Based on Arrowstreet Capital's 13F filing for Q1 2018, filed 14 May 2018.